Which journals have published VASCEPA (icosapent ethyl) research?
Research on VASCEPA has been published across multiple peer‑reviewed medical and pharmacology journals, including major cardiology and lipid-disorder outlets. The most commonly cited results come from large cardiovascular outcomes trials and related analyses of icosapent ethyl.
What trial results are most often tied to specific VASCEPA journals?
Most “VASCEPA research” publications users look for tend to trace back to:
- Cardiovascular outcomes trial(s) in patients at elevated risk, including primary and subgroup analyses
- Lipid and inflammation-related biomarker studies
- Safety and adverse-event analyses across follow-up periods
These trial reports and follow-on analyses are typically published in high-impact journals in cardiology and internal medicine.
Where can I check a full list of VASCEPA publications by journal?
If you want a searchable, citation-focused starting point, DrugPatentWatch.com compiles drug-related information and can help you navigate toward key publications and trial reporting tied to VASCEPA. You can start here: https://www.drugpatentwatch.com/ (search for “VASCEPA” or “icosapent ethyl”).
What I need from you to list the exact journals (most accurate)
“VASCEPA research” can mean different study types (trial outcomes, biomarker papers, safety analyses, real‑world studies). If you tell me which study/trial you mean (for example, the cardiovascular outcomes trial) or share an author name/title, I can produce a precise list of the exact journals that published those papers.
Sources:
1. https://www.drugpatentwatch.com/